Lawmakers grilled U.S. Food and Drug Administration officials on Wednesday over what they saw as a lack of urgency in the agency’s response to complaints about possible baby formula contamination at a now shuttered Abbott Laboratories plant that led to severe nationwide shortages.
If you are not happy with the results below please do another search
50 search results for:
Eli Lilly is expanding the Indianapolis-based company’s footprint in Indiana through a $2.1 billion investment.
Janssen Pharmaceutical shared positive updates from ongoing trials on candidate therapies for Crohn’s disease (CD) and ulcerative colitis (UC) at Digestive Disease Week in San Diego, California.
Bacteria in Antarctica have been discovered with genes that give them natural antibiotic and antimicrobial resistance and have the potential to spread out of the polar regions, according to scientists in Chile.
Roche on Wednesday said the company and its unit have developed three test kits to detect the monkeypox virus, as the disease spreads in regions outside Africa, where the virus is not normally found.
Servier today announced that the U.S. Food and Drug Administration approved TIBSOVO (ivosidenib tablets) in combination with azacitidine for the treatment of patients with newly diagnosed IDH1-mutated acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
Teva Pharmaceutical Industries and AbbVie’s Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said on Wednesday.
Verrica Pharmaceuticals has received the company’s third Complete Response Letter (CRL) from the U.S. Food and Drug Administration for its New Drug Application for the molluscum contagiosum treatment candidate VP-102.
United Therapeutics announced on Tuesday that the company received U.S. Food and Drug Administration approval for its therapeutic Tyvaso DPI. Tyvaso DPI marks the first approval of a dry powder inhaler for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
World Health Organization members formally agreed on Tuesday to a plan to overhaul its funding model which has been described as “fundamentally rotten” due to an over-reliance on the whims of donors.